ApoE genotyping as a progression-rate biomarker in phase II disease-modification trials for Alzheimer's disease

被引：16
作者：
Stone, D. J. [1 ]
Molony, C. [2 ]
Suver, C. [2 ]
Schadt, E. E. [2 ]
Potter, W. Z. [3 ]
机构：
[1] Merck Res Labs, West Point, PA 19486 USA
[2] Rosetta Inpharmat LLC, Seattle, WA USA
[3] Merck Res Labs, Dept Neurosci & Ophthalmol, N Wales, PA USA
来源：
PHARMACOGENOMICS JOURNAL | 2010年 / 10卷 / 03期
关键词：
COGNITIVE DECLINE; APOLIPOPROTEIN-E; EPSILON-4; ALLELE; ROFECOXIB; GENE;
D O I：
10.1038/tpj.2009.58
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：161 / 164
页数：4
相关论文
共 16 条
[1]   Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression - A randomized controlled trial [J].
Aisen, PS ;
Schafer, KA ;
Grundman, M ;
Pfeiffer, E ;
Sano, M ;
Davis, KL ;
Farlow, MR ;
Jin, S ;
Thomas, RG ;
Thal, LJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (21) :2819-2826
[2]   Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene and the rate of cognitive decline in Alzheimer's disease [J].
Belbin, Olivia ;
Dunn, Janette L. ;
Ling, Yan ;
Morgan, Linda ;
Chappell, Sally ;
Beaumont, Helen ;
Warden, Donald ;
Smith, David A. ;
Kalsheker, Noor ;
Morgan, Kevin .
HUMAN MOLECULAR GENETICS, 2007, 16 (18) :2199-2208
[3]   Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses [J].
Bertram, Lars ;
Tanzi, Rudolph E. .
NATURE REVIEWS NEUROSCIENCE, 2008, 9 (10) :768-778
[4]   GENE DOSE OF APOLIPOPROTEIN-E TYPE-4 ALLELE AND THE RISK OF ALZHEIMERS-DISEASE IN LATE-ONSET FAMILIES [J].
CORDER, EH ;
SAUNDERS, AM ;
STRITTMATTER, WJ ;
SCHMECHEL, DE ;
GASKELL, PC ;
SMALL, GW ;
ROSES, AD ;
HAINES, JL ;
PERICAKVANCE, MA .
SCIENCE, 1993, 261 (5123) :921-923
[5]   APOE ε4 allele predicts faster cognitive decline in mild Alzheimer disease [J].
Cosentino, S. ;
Scarmeas, N. ;
Helzner, E. ;
Glymour, M. M. ;
Brandt, J. ;
Albert, M. ;
Blacker, D. ;
Stern, Y. .
NEUROLOGY, 2008, 70 (19) :1842-1849
[6]   Accelerated decline in apolipoprotein E-ε4 homozygotes with Alzheimer's disease [J].
Craft, S ;
Teri, L ;
Edland, SD ;
Kukull, WA ;
Schellenberg, G ;
McCormick, WC ;
Bowen, JD ;
Larson, EB .
NEUROLOGY, 1998, 51 (01) :149-153
[7]   GENE DOSE OF THE EPSILON-4 ALLELE OF APOLIPOPROTEIN-E AND DISEASE PROGRESSION IN SPORADIC LATE-ONSET ALZHEIMERS-DISEASE [J].
FRISONI, GB ;
GOVONI, S ;
GEROLDI, C ;
BIANCHETTI, A ;
CALABRESI, L ;
FRANCESCHINI, G ;
TRABUCCHI, M .
ANNALS OF NEUROLOGY, 1995, 37 (05) :596-604
[8]   Individual growth curve analysis of APOE ε4-associated cognitive decline in Alzheimer disease [J].
Hoyt, BD ;
Massman, PJ ;
Schatschneider, C ;
Cooke, N ;
Doody, RS .
ARCHIVES OF NEUROLOGY, 2005, 62 (03) :454-459
[9]   Rate of cognitive decline and mortality in Alzheimer's disease [J].
Hui, JS ;
Wilson, RS ;
Bennett, DA ;
Bienias, JL ;
Gilley, DW ;
Evans, DA .
NEUROLOGY, 2003, 61 (10) :1356-1361
[10]   APOE alleles predict the rate of cognitive decline in Alzheimer disease -: A nonlinear model [J].
Martins, CAR ;
Oulhaj, A ;
de Jager, CA ;
Williams, JH .
NEUROLOGY, 2005, 65 (12) :1888-1893
12